Zobrazeno 1 - 10
of 175
pro vyhledávání: '"Giorgio, Minotti"'
Autor:
Massimiliano Camilli, Marcello Viscovo, Tamara Felici, Luca Maggio, Federico Ballacci, Giacomo Carella, Alice Bonanni, Priscilla Lamendola, Lorenzo Tinti, Antonio Di Renzo, Giulia Coarelli, Eugenio Galli, Giovanna Liuzzo, Francesco Burzotta, Rocco Antonio Montone, Federica Sorà, Simona Sica, Stefan Hohaus, Gaetano Antonio Lanza, Filippo Crea, Antonella Lombardo, Giorgio Minotti
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Aims Chimeric Antigen Receptor-T (CAR-T) cell infusion is a rapidly evolving antitumor therapy; however, cardiovascular (CV) complications, likely associated with cytokine release syndrome (CRS) and systemic inflammation, have been reported
Externí odkaz:
https://doaj.org/article/5e8e04e36d954716847928760804ce10
Autor:
Pierantonio Menna, Francesco Marchesi, Chiara Cattaneo, Anna Candoni, Mario Delia, Gianpaolo Nadali, Alessandra Vatteroni, Crescenza Pasciolla, Salvatore Perrone, Luisa Verga, Daniele Armiento, Maria Ilaria Del Principe, Nicola S. Fracchiolla, Emanuela Salvatorelli, Santina Lupisella, Irene Terrenato, Alessandro Busca, Giorgio Minotti, Livio Pagano
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 10, Pp 1876-1885 (2023)
Abstract Midostaurin is used in combination with chemotherapy to treat patients with newly diagnosed FLT3‐mutated acute myeloid leukemia. Chemotherapy‐induced neutropenia exposes these patients to a significant risk of invasive fungal infections
Externí odkaz:
https://doaj.org/article/ae0502c15a614d09b16812729bd45226
Autor:
Massimiliano Camilli, Juan Guido Chiabrando, Marco Lombardi, Marco Giuseppe Del Buono, Rocco Antonio Montone, Antonella Lombardo, Filippo Crea, Giorgio Minotti
Publikováno v:
Cardio-Oncology, Vol 9, Iss 1, Pp 1-7 (2023)
Abstract Background Several cohort studies aimed at demonstrating an increased risk of cancer incidence and mortality in patients with a pre-existing diagnosis of heart failure (HF); however, conflicting results have been reported that call for syste
Externí odkaz:
https://doaj.org/article/53f8ff9637d24fe995c6c54f24c661f2
Publikováno v:
Cardio-Oncology, Vol 6, Iss 1, Pp 1-4 (2020)
Abstract Sacubitril/Valsartan (S/V) is a novel and remarkably effective opportunity to treat heart failure with reduced ejection fraction (HFrEF). However, patients with HFrEF induced by cancer therapy were a priori excluded from the registration stu
Externí odkaz:
https://doaj.org/article/d3ca4b12ccd647c9aeeed9bd87a4e415
Autor:
Massimiliano Camilli, MD, Marco Giuseppe Del Buono, MD, Filippo Crea, MD, PhD, Giorgio Minotti, MD, PhD
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 2, Pp 316-319 (2020)
Externí odkaz:
https://doaj.org/article/6feba33d530848e182aac46a9aad9c96
Publikováno v:
Chemotherapy.
Background Acute myeloid leukemia (AML) is a life-threatening disease whose treatment is made difficult by a number of mutations or receptor overexpression in the proliferating cellular clones. Life expectancy of patients diagnosed with new, relapsed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41f9f2ada09120c993f427549a6099d6
https://doi.org/10.1159/000530447
https://doi.org/10.1159/000530447
Autor:
Giorgio Minotti, Emanuela Salvatorelli, Giorgio Reggiardo, Fabio Mangiacapra, Massimiliano Camilli, Pierantonio Menna
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 381:266-273
Diastolic dysfunction (DD) was reported to precede heart failure (HF) in patients with cancer who were treated with chemotherapy. We aimed at defining risk versus dose relationships and risk predictors in patients with cancer treated mainly with anth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31032a7b361d880491c34878a9e2494b
https://doi.org/10.1124/jpet.122.001101
https://doi.org/10.1124/jpet.122.001101
Autor:
Joerg Herrmann, Daniel Lenihan, Saro Armenian, Ana Barac, Anne Blaes, Daniela Cardinale, Joseph Carver, Susan Dent, Bonnie Ky, Alexander R Lyon, Teresa López-Fernández, Michael G Fradley, Sarju Ganatra, Giuseppe Curigliano, Joshua D Mitchell, Giorgio Minotti, Ninian N Lang, Jennifer E Liu, Tomas G Neilan, Anju Nohria, Rupal O'Quinn, Iskra Pusic, Charles Porter, Kerry L Reynolds, Kathryn J Ruddy, Paaladinesh Thavendiranathan, Peter Valent
Publikováno v:
Eur Heart J
The discipline of Cardio-Oncology has seen tremendous growth over the past decade. It is devoted to the cardiovascular (CV) care of the cancer patient, especially to the mitigation and management of CV complications or toxicities of cancer therapies,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43dfe49af9751871e3b808d437fc252e
https://doi.org/10.1093/eurheartj/ehab674
https://doi.org/10.1093/eurheartj/ehab674
Autor:
Massimiliano Camilli, Marco Lombardi, Juan G. Chiabrando, Andrea Zito, Marco G. Del Buono, Rocco Vergallo, Nadia Aspromonte, Antonella Lombardo, Rocco A. Montone, Giampaolo Niccoli, Giuseppe Biondi-Zoccai, Filippo Crea, Giorgio Minotti
Publikováno v:
American Journal of Therapeutics. 29:e199-e204
Recent trials demonstrated the clinical efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with heart failure (HF), regardless of the presence or absence of type 2 diabetes. These data may allow the use of this innovative drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b892d3b2819117e8714e29b42b926b2
https://doi.org/10.1097/mjt.0000000000001452
https://doi.org/10.1097/mjt.0000000000001452
Publikováno v:
Chemotherapy.
Background: The natural history of chronic lymphocytic leukemia (CLL) was dramatically improved by the introduction of ibrutinib, a Bruton’s kinase (BTK) inhibitor. In this review we aimed to summarize and critically evaluate the association betwee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3587663ec45088ad899ecf65c5894c5
https://pubmed.ncbi.nlm.nih.gov/36366814
https://pubmed.ncbi.nlm.nih.gov/36366814